Latest news with #Cibus'
Yahoo
a day ago
- Business
- Yahoo
Cibus says USDA designates HT2 as ‘not regulated' under biotech regulations
Cibus (CBUS) announced that its most recent trait for its herbicide tolerance trait in Canola has been designated as 'not regulated' by the United States Department of Agriculture's Animal and Plant Health Inspection Service Biotechnology Regulatory Services as Plant Pests or Which There is Reason to Believe Are Plant Pests, as described in 7 CFR part 340. Consistent with other Cibus developed and advanced traits developed utilizing Cibus' Rapid Trait Development System, this most recent USDA-APHIS regulatory determination, along with others recently announced, brings Cibus' total number of traits designated as not regulated to seventeen. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on CBUS: Disclaimer & DisclosureReport an Issue Cibus Stock (CBUS) Plummets 30% on Public Offering Pricing Morning News Wrap-Up: Thursday's Biggest Stock Market Stories Cibus prices 15.7M shares at $1.75 in public offering Cibus Announces Strategic Realignment to Streamline Operations Cibus announces Class A common stock offering, no amount given
Yahoo
19-05-2025
- Business
- Yahoo
Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will host a presentation at the AGP Annual Virtual Healthcare Company Showcase. During the presentation, Dr. Beetham will discuss the Company's progress in advancing its gene-editing technology platform, recent regulatory developments supporting agricultural innovation, and Cibus' commercialization strategy for its productivity trait pipeline. Presentation DetailsDate: Wednesday, May 21, 2025 Time: 4:40 p.m. ET (1:40 p.m. PT) Webcast link: About Cibus Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus. CIBUS CONTACTS: INVESTOR RELATIONSKaren Troeberktroeber@ Jeff Sonnek – ICR RELATIONSColin Sanfordcolin@
